Changes in the Urinary Metabolites in Losartan-Treated Spontaneously Hypertensive Rats / Norasikin Ab Azis ...[et al.]

Ab Azis, Norasikin and Ahmad Kamal, Mohd Saleh and Radjeni, Zurain and Mediani, Ahmed and Agarwal, Renu (2021) Changes in the Urinary Metabolites in Losartan-Treated Spontaneously Hypertensive Rats / Norasikin Ab Azis ...[et al.]. Journal of Clinical and Health Sciences, 6 (1). pp. 32-45. ISSN 0127 – 984X

Download

[thumbnail of 44354.pdf] Text
44354.pdf

Download (598kB)

Abstract

Introduction: This study examined the association of losartan induced changes in urinary metabolomic profile with the changes in blood pressure (BP) and renin-angiotensin- aldosterone system (RAAS) in spontaneously hypertensive rats (SHR). Methods: Male SHR were administered with either 0.5 mL of distilled water (control group, n=6) or 10 mg.kg-1 of losartan (group 2, n=6) daily by oral gavage for 4 weeks. Body weight, BP, food and water intake were measured weekly. At week 4, urine was collected for urinary electrolyte analysis and metabolite profiling, after which the animals were euthanised by decapitation and blood was collected for analysis of components of RAAS and electrolyte concentrations. Urine metabolite profile of SHR was determined using proton nuclear magnetic resonance (1H-NMR) spectrometry combined with multivariate data analysis. Results: At week 4, losartan-treated SHR had significantly lower BP than non-treated SHR. There were no differences in water and food intake, body weight, serum and urinary electrolyte concentrations or in their urinary excretions between the two groups. No differences were evident in the components of RAAS except that the angiotensinogen level was significantly higher in losartan-treated SHR compared to non-treated SHR. Orthogonal partial least squares discriminant analysis (OPLS- DA) showed clear separation of urinary metabolites between control and losartan-treated SHR. Losartan-treated SHR group was separated from the control group by changes in the intermediates involved in glycine, serine and threonine metabolism. Conclusion: Antihypertensive effect of losartan in SHR seems to be associated with changes in urinary metabolite profile, particularly involving the metabolism of glycine, serine and threonine.

Metadata

Item Type: Article
Creators:
Creators
Email
Ab Azis, Norasikin
UNSPECIFIED
Ahmad Kamal, Mohd Saleh
UNSPECIFIED
Radjeni, Zurain
UNSPECIFIED
Mediani, Ahmed
UNSPECIFIED
Agarwal, Renu
UNSPECIFIED
Subjects: Q Science > QP Physiology > Urinary and reproductive organs
Q Science > QP Physiology > Animal biochemistry
R Medicine > R Medicine (General)
Divisions: Universiti Teknologi MARA, Selangor > Puncak Alam Campus > Faculty of Medicine
Journal or Publication Title: Journal of Clinical and Health Sciences
UiTM Journal Collections: UiTM Journal > Journal of Clinical and Health Sciences (JCHS)
ISSN: 0127 – 984X
Volume: 6
Number: 1
Page Range: pp. 32-45
Official URL: https://jchs-medicine.uitm.edu.my/index.php
Item ID: 44354
Uncontrolled Keywords: 1H-NMR, metabolomics, hypertension, losartan, spontaneously hypertensive rats, RAAS
URI: https://ir.uitm.edu.my/id/eprint/44354

ID Number

44354

Indexing


View in Google Scholar

Edit Item
Edit Item